|
BICD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00939999994709E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.289600000007E-05 |
| Normal-vs-Stage2 |
9.78719999999988E-05 |
| Normal-vs-Stage3 |
2.845800E-04 |
| Normal-vs-Stage4 |
2.34889999999321E-05 |
| Stage1-vs-Stage2 |
2.538400E-01 |
| Stage1-vs-Stage3 |
5.801800E-01 |
| Stage1-vs-Stage4 |
1.769400E-01 |
| Stage2-vs-Stage3 |
5.842000E-01 |
| Stage2-vs-Stage4 |
8.905000E-01 |
| Stage3-vs-Stage4 |
4.726000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53480999999234E-05 |
| Normal-vs-AfricanAmerican |
5.779800E-02 |
| Normal-vs-Asian |
5.844000E-02 |
| Caucasian-vs-AfricanAmerican |
4.099800E-01 |
| Caucasian-vs-Asian |
1.912810E-01 |
| AfricanAmerican-vs-Asian |
8.866400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93309999999103E-06 |
| Normal-vs-Female |
1.8061499999944E-05 |
| Male-vs-Female |
3.519800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.825600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.90580000003493E-06 |
| Normal-vs-Age(61-80Yrs) |
4.77379999996863E-06 |
| Normal-vs-Age(81-100Yrs) |
9.537900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.085180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.218200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.151200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.861400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.091800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.333800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.583200E-01 |
| Classical-VS-Follicular |
1.358080E-04 |
| Classical-VS-Other |
3.506400E-01 |
| Classical-VS-Normal |
3.497000E-03 |
| Tall-VS-Follicular |
1.472820E-01 |
| Tall-VS-Other |
6.133800E-01 |
| Tall-VS-Normal |
6.165700E-02 |
| Follicular-VS-Other |
7.362000E-01 |
| Follicular-VS-Normal |
4.67399999815044E-08 |
| Other-VS-Normal |
2.494400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.71659999840202E-08 |
| Normal-vs-N1 |
1.414670E-04 |
| N0-vs-N1 |
9.193600E-01 |
|
|
